Myelomeningocele: the Evolution of Care over the Last 50 years

Overview

Journal Childs Nerv Syst

Specialty Pediatrics

Date 2023 Jul 7

PMID 37417984

Authors

Robin M Bowman

Ji Yeoun Lee

Jeyul Yang

Kyung Hyun Kim

Kyu-Chang Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: Myelomeningocele (MMC) is one of the representative anomalies in the field of pediatric neurosurgery. During the 50 years of ISPN history, MMC had a tremendous changes in its incidence, clinical management and outcome with advanced understanding of its pathogenesis. We reviewed the changes in MMC during the period.

Methods: We reviewed the literature review and collected our experiences.

Results: During the 50 years, major changes happened in many aspects of MMC including incidence, pathoembryogenesis, folate deficiency, prevention, prenatal diagnosis, mode of delivery, treatment policy with ethical considerations, clinical treatment including fetal surgery, latex allergy, retethering, management outcome, multidisciplinary team approach, and socioeconomic and family issues.

Conclusions: There was a great advance in the management and research of MMC during the 50 years. It is a monumental achievement of pediatric neurosurgeons and colleagues of the related fields.

References

Fletcher J, Copeland K, Frederick J, Blaser S, Kramer L, Northrup H . Spinal lesion level in spina bifida: a source of neural and cognitive heterogeneity. J Neurosurg. 2005; 102(3 Suppl):268-79. DOI: 10.3171/ped.2005.102.3.0268. View

Lammer E, Sever L, Oakley Jr G . Teratogen update: valproic acid. Teratology. 1987; 35(3):465-73. DOI: 10.1002/tera.1420350319. View

Copp A, Scott Adzick N, Chitty L, Fletcher J, Holmbeck G, Shaw G . Spina bifida. Nat Rev Dis Primers. 2016; 1:15007. PMC: 4898641. DOI: 10.1038/nrdp.2015.7. View

Copp A, Greene N, Murdoch J . The genetic basis of mammalian neurulation. Nat Rev Genet. 2003; 4(10):784-93. DOI: 10.1038/nrg1181. View

Harris M, Juriloff D . Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2006; 79(3):187-210. DOI: 10.1002/bdra.20333. View

Shimoji K, Kimura T, Kondo A, Tange Y, Miyajima M, Arai H . Genetic studies of myelomeningocele. Childs Nerv Syst. 2013; 29(9):1417-25. DOI: 10.1007/s00381-013-2197-2. View

Copp A, Stanier P, Greene N . Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 2013; 12(8):799-810. PMC: 4023229. DOI: 10.1016/S1474-4422(13)70110-8. View

Lee J, Kim J, Shim Y, Kim S, Kim K, Yang J . Myelomeningocele as an anomaly of secondary neurulation. Childs Nerv Syst. 2022; 38(11):2091-2099. DOI: 10.1007/s00381-022-05591-8. View

Pitkin R . Folate and neural tube defects. Am J Clin Nutr. 2007; 85(1):285S-288S. DOI: 10.1093/ajcn/85.1.285S. View

10.

HIBBARD B . THE ROLE OF FOLIC ACID IN PREGNANCY; WITH PARTICULAR REFERENCE TO ANAEMIA, ABRUPTION AND ABORTION. J Obstet Gynaecol Br Commonw. 1964; 71:529-42. DOI: 10.1111/j.1471-0528.1964.tb04317.x. View

11.

Bower C, Stanley F . Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust. 1989; 150(11):613-9. DOI: 10.5694/j.1326-5377.1989.tb136723.x. View

12.

Laurence K, James N, Miller M, Tennant G, Campbell H . Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed). 1981; 282(6275):1509-11. PMC: 1505459. DOI: 10.1136/bmj.282.6275.1509. View

13.

Mulinare J, Cordero J, Erickson J, Berry R . Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988; 260(21):3141-5. View

14.

Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement. JAMA. 2017; 317(2):183-189. DOI: 10.1001/jama.2016.19438. View

15.

Cordero A, Crider K, Rogers L, Cannon M, Berry R . Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb Mortal Wkly Rep. 2015; 64(15):421-3. PMC: 5779552. View

16.

Blom H . Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol Teratol. 2009; 85(4):295-302. DOI: 10.1002/bdra.20581. View

17.

Liu H, Liu S, Zhang Y . Maternal Folic Acid Supplementation Mediates Offspring Health via DNA Methylation. Reprod Sci. 2020; 27(4):963-976. DOI: 10.1007/s43032-020-00161-2. View

18.

Wang L, Wang F, Guan J, Le J, Wu L, Zou J . Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am J Clin Nutr. 2010; 91(5):1359-67. DOI: 10.3945/ajcn.2009.28858. View

19.

Cao R, Xie J, Zhang L . Abnormal methylation caused by folic acid deficiency in neural tube defects. Open Life Sci. 2023; 17(1):1679-1688. PMC: 9784971. DOI: 10.1515/biol-2022-0504. View

20.

Crider K, Yang T, Berry R, Bailey L . Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012; 3(1):21-38. PMC: 3262611. DOI: 10.3945/an.111.000992. View